Crossmark

IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases

Crossref DOI link: https://doi.org/10.1038/nm.3895

Published Online: 2015-06-29

Published Print: 2015-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Teng, Michele W L http://orcid.org/0000-0003-1886-9145
Bowman, Edward P

McElwee, Joshua J

Smyth, Mark J

Casanova, Jean-Laurent

Cooper, Andrea M

Cua, Daniel J
License Information

Text and Data Mining valid from 2015-06-29
More Information

Article History

Received: 3 December 2014

Accepted: 5 May 2015

First Online: 29 June 2015

Competing interests

: D.J.C., J.J.M., and E.P.B. are employed by Merck and Co. M.W.L.T. has received research grants from AMGEN. J.-L.C. has received research grants from Merck. M.J.S. has a scientific research agreement with Bristol-Myers Squibb.